Health Coaching for Glaucoma Patients

NCT ID: NCT02090777

Last Updated: 2016-03-14

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 9 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2014-05-31
• Study Completion Date: 2015-04-30

Brief Summary

The study will be conducted to examine the feasibility of using a Health Coach for improving the ophthalmic care of glaucoma patients. Patients taking glaucoma medications will have a coaching intervention and adherence to glaucoma drops will be monitored using a dose-recording device. The dosing data will be analyzed to examine the effect on adherence and qualitative interviews at the conclusion of the study will be used to examine which elements of the coaching experience were most helpful in the glaucoma patient population.

Detailed Description

Glaucoma medication adherence will be tracked using a dose recording device to record eye drop usage.

Conditions

Glaucoma

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Health Coach

Health Coach is conducted to see if it improves ophthalmic care for glaucoma patients.

Group Type: OTHER

Health Coach

Intervention Type: BEHAVIORAL

Interventions

Health Coach

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Adult whose age is >18 years
• Diagnosed with glaucoma
• Patient of Duke Glaucoma Service
• Prescribed or using topical glaucoma eye medication for at least 6 months
• Primarily self-administering his or her eye drops
• English speaking
• Patient should be able to use the telephone for the coaching intervention,
• Patient should be available by phone to complete the coaching intervention
• Patient should be willing and able to use the MEMS (Medication Event Monitoring System) device for recording medication use
• Patient must be willing and able to come to the Eye Center for an exit interview and to return the MEMS device
• Patient must be able to give consent

Exclusion Criteria

• Patient should be excluded if he or she may need glaucoma surgery or laser during the 6 months of the study period

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Duke University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Jullia Rosdahl, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Duke Eye Center

Durham, North Carolina, United States

Countries

United States

Other Identifiers

Pro00052498

Identifier Type: -

Identifier Source: org_study_id